ConductScience.org, home

Trial · NCT07897331

Registered outcomes24

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryCorrelation between early heart rate variability (ln RMSSD) and quality of recovery (ObsQoR-11T)First 24 hours postpartum
Correlation (Pearson or Spearman, per distribution) between early postoperative HRV (natural log of RMSSD over the first 24 hours) and the ObsQoR-11T total score (range 0-110; higher = better recovery) at 24 hours postpartum.
SecondaryObsQoR-11T total score24 and 48 hours postpartumObstetric Quality of Recovery score, validated Turkish version (ObsQoR-11T); 11 items, total range 0-110 (higher = better recovery).
SecondarySubjective sleep quality (Richards-Campbell Sleep Questionnaire, RCSQ)24 and 48 hours postpartumRCSQ total score, calculated as the mean of the first 5 items (range 0-100; higher = better sleep).
SecondaryStandard deviation of NN intervals (SDNN)First 48 hours after cesarean delivery
Time-domain heart rate variability computed from raw beat-to-beat intervals recorded by a wrist-worn wearable (Garmin Vivosmart 5) and processed on the Fitrockr platform. Reported in milliseconds from analyzable nocturnal 5-minute segments.
SecondaryProportion of successive NN intervals differing by more than 50 ms (pNN50)First 48 hours after cesarean delivery
Time-domain heart rate variability computed from raw beat-to-beat intervals recorded by a wrist-worn wearable (Garmin Vivosmart 5) and processed on the Fitrockr platform. Reported as a percentage of successive interval pairs from analyzable nocturnal 5-minute segments.
SecondaryLow-frequency power of heart rate variability (LF)First 48 hours after cesarean delivery
Frequency-domain heart rate variability (0.04-0.15 Hz) computed from raw beat-to-beat intervals recorded by a wrist-worn wearable (Garmin Vivosmart 5) and processed on the Fitrockr platform. Reported as absolute power in squared milliseconds from analyzable nocturnal 5-minute segments.
SecondaryHigh-frequency power of heart rate variability (HF)First 48 hours after cesarean delivery
Frequency-domain heart rate variability (0.15-0.40 Hz) computed from raw beat-to-beat intervals recorded by a wrist-worn wearable (Garmin Vivosmart 5) and processed on the Fitrockr platform. Reported as absolute power in squared milliseconds from analyzable nocturnal 5-minute segments.
SecondaryRatio of low-frequency to high-frequency power (LF/HF)First 48 hours after cesarean delivery
Ratio of absolute low-frequency to high-frequency heart rate variability power, computed from raw beat-to-beat intervals recorded by a wrist-worn wearable (Garmin Vivosmart 5) and processed on the Fitrockr platform. Reported as a unitless ratio from analyzable nocturnal 5-minute segments.
SecondaryRatio of Poincare plot descriptors SD1 to SD2First 48 hours after cesarean delivery
Non-linear heart rate variability index computed from raw beat-to-beat intervals recorded by a wrist-worn wearable (Garmin Vivosmart 5) and processed on the Fitrockr platform. Reported as a unitless ratio from analyzable nocturnal 5-minute segments.
SecondaryNatural log of RMSSD at fixed postoperative time windows12, 24, 36 and 48 hours after cesarean delivery
Natural logarithm of the root mean square of successive beat-to-beat interval differences, computed from raw beat-to-beat intervals recorded by a wrist-worn wearable (Garmin Vivosmart 5) and processed on the Fitrockr platform, at fixed postoperative windows. Reported as ln(ms).
SecondaryMean heart rate at fixed postoperative time windows12, 24, 36 and 48 hours after cesarean deliveryMean heart rate derived from the wrist-worn wearable (Garmin Vivosmart 5) via the Fitrockr platform at fixed postoperative windows, reported in beats per minute.
SecondaryTotal sleep time measured by the wearable deviceFirst 48 hours after cesarean deliveryTotal sleep time derived from the wrist-worn wearable (Garmin Vivosmart 5) via the Fitrockr platform, reported in minutes.
SecondarySleep efficiency measured by the wearable deviceFirst 48 hours after cesarean deliveryTotal sleep time divided by time in bed, derived from the wrist-worn wearable (Garmin Vivosmart 5) via the Fitrockr platform and reported as a percentage.
SecondaryNumber of awakenings measured by the wearable deviceFirst 48 hours after cesarean deliveryCount of awakenings during the sleep period, derived from the wrist-worn wearable (Garmin Vivosmart 5) via the Fitrockr platform.
SecondaryAgreement between objective (device) and subjective (RCSQ) sleepFirst 48 hours postpartumCorrelation/agreement between wearable-derived sleep parameters and the RCSQ score.
SecondaryPain at rest on a numeric rating scale24 and 48 hours after cesarean deliveryPatient-reported pain intensity at rest on a numeric rating scale from 0 to 10, where 0 is no pain and 10 is the worst imaginable pain.
SecondaryPain on movement on a numeric rating scale24 and 48 hours after cesarean deliveryPatient-reported pain intensity on movement on a numeric rating scale from 0 to 10, where 0 is no pain and 10 is the worst imaginable pain.
SecondaryTotal opioid consumption in oral morphine milligram equivalentsFirst 48 hours after cesarean deliveryCumulative opioid dose administered after cesarean delivery, converted to oral morphine milligram equivalents and recorded from the medication chart.
SecondaryChange in ObsQoR-11T from 24 to 48 hours24 to 48 hours postpartumDifference in ObsQoR-11T total score (range 0-110; higher = better recovery) between 24 and 48 hours postpartum, and its association with early HRV and sleep.
SecondaryMean device-derived stress scoreFirst 48 hours after cesarean delivery
Mean of minute-level stress scores recorded by the wrist-worn wearable (Garmin Vivosmart 5; proprietary 0-100 scale derived from heart rate variability, higher values indicate greater physiological stress) and exported via the Fitrockr platform, averaged over all valid minutes. Reported as score units on a 0-100 scale.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07897331/registered